Global Solid Tumors Drugs Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Published Date : Feb-2017   |    Format :PDF   |    Number of Pages : 112
Notes:
Production, means the output of Solid Tumors Drugs
Revenue, means the sales value of Solid Tumors Drugs

This report studies Solid Tumors Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
    Hoffmann-La Roche
    Novartis
    Celgene
    Johnson & Johnson
    Pfizer
    BMS
    AbbVie
    AbGenomics
    ADC Therapeutics
    TG Therapeutics
    Polaris Pharmaceuticals
    Immunogen
    CTI BioPharma
    Chugai Pharmaceutical
    NewLink Genetics
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Solid Tumors Drugs in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
Split by application, this report focuses on consumption, market share and growth rate of Solid Tumors Drugs in each application, can be divided into
    Application 1
    Application 2

Global Solid Tumors Drugs Market Research Report 2017
1 Solid Tumors Drugs Market Overview
    1.1 Product Overview and Scope of Solid Tumors Drugs
    1.2 Solid Tumors Drugs Segment by Type
        1.2.1 Global Production Market Share of Solid Tumors Drugs by Type in 2015
        1.2.2 Type I
        1.2.3 Type II
    1.3 Solid Tumors Drugs Segment by Application
        1.3.1 Solid Tumors Drugs Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
    1.4 Solid Tumors Drugs Market by Region
        1.4.1 North America Status and Prospect (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 China Status and Prospect (2012-2022)
        1.4.4 Japan Status and Prospect (2012-2022)
        1.4.5 Southeast Asia Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Solid Tumors Drugs (2012-2022)

2 Global Solid Tumors Drugs Market Competition by Manufacturers
    2.1 Global Solid Tumors Drugs Production and Share by Manufacturers (2015 and 2016)
    2.2 Global Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global Solid Tumors Drugs Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Solid Tumors Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Solid Tumors Drugs Market Competitive Situation and Trends
        2.5.1 Solid Tumors Drugs Market Concentration Rate
        2.5.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Solid Tumors Drugs Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Solid Tumors Drugs Production and Market Share by Region (2012-2017)
    3.2 Global Solid Tumors Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.3 Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.4 North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Solid Tumors Drugs Supply (Production), Consumption, Export, Import by Regions (2012-2017)
    4.1 Global Solid Tumors Drugs Consumption by Regions (2012-2017)
    4.2 North America Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Solid Tumors Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Solid Tumors Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Solid Tumors Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Solid Tumors Drugs Price by Type (2012-2017)
    5.4 Global Solid Tumors Drugs Production Growth by Type (2012-2017)

6 Global Solid Tumors Drugs Market Analysis by Application
    6.1 Global Solid Tumors Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Solid Tumors Drugs Manufacturers Profiles/Analysis
    7.1 Hoffmann-La Roche
        7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.1.2 Solid Tumors Drugs Product Type, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.1.4 Main Business/Business Overview
    7.2 Novartis
        7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.2.2 Solid Tumors Drugs Product Type, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.2.4 Main Business/Business Overview
    7.3 Celgene
        7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.3.2 Solid Tumors Drugs Product Type, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.3.4 Main Business/Business Overview
    7.4 Johnson & Johnson
        7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.4.2 Solid Tumors Drugs Product Type, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.4.4 Main Business/Business Overview
    7.5 Pfizer
        7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.5.2 Solid Tumors Drugs Product Type, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.5.4 Main Business/Business Overview
    7.6 BMS
        7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.6.2 Solid Tumors Drugs Product Type, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.6.4 Main Business/Business Overview
    7.7 AbbVie
        7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.7.2 Solid Tumors Drugs Product Type, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.7.4 Main Business/Business Overview
    7.8 AbGenomics
        7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.8.2 Solid Tumors Drugs Product Type, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.8.4 Main Business/Business Overview
    7.9 ADC Therapeutics
        7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.9.2 Solid Tumors Drugs Product Type, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.9.4 Main Business/Business Overview
    7.10 TG Therapeutics
        7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.10.2 Solid Tumors Drugs Product Type, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.10.4 Main Business/Business Overview
    7.11 Polaris Pharmaceuticals
    7.12 Immunogen
    7.13 CTI BioPharma
    7.14 Chugai Pharmaceutical
    7.15 NewLink Genetics

8 Solid Tumors Drugs Manufacturing Cost Analysis
    8.1 Solid Tumors Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Solid Tumors Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Solid Tumors Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Solid Tumors Drugs Market Forecast (2017-2022)
    12.1 Global Solid Tumors Drugs Production, Revenue and Price Forecast (2017-2022)
        12.1.1 Global Solid Tumors Drugs Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Solid Tumors Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Solid Tumors Drugs Production, Consumption , Import and Export Forecast by Regions (2017-2022)
        12.2.1 North America Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Solid Tumors Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Solid Tumors Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Solid Tumors Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures

Figure Picture of Solid Tumors Drugs
Figure Global Production Market Share of Solid Tumors Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Solid Tumors Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure North America Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Solid Tumors Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Solid Tumors Drugs Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Solid Tumors Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Production Share by Manufacturers
Figure 2016 Solid Tumors Drugs Production Share by Manufacturers
Table Global Solid Tumors Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table Global Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Solid Tumors Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Solid Tumors Drugs Product Type
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table Global Solid Tumors Drugs Production by Regions (2012-2017)
Figure Global Solid Tumors Drugs Production and Market Share by Regions (2012-2017)
Figure Global Solid Tumors Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Solid Tumors Drugs Production Market Share by Regions
Table Global Solid Tumors Drugs Revenue by Regions (2012-2017)
Table Global Solid Tumors Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Solid Tumors Drugs Revenue Market Share by Regions
Table Global Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Solid Tumors Drugs Consumption Market by Regions (2012-2017)
Table Global Solid Tumors Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Solid Tumors Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Solid Tumors Drugs Consumption Market Share by Regions
Table North America Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table China Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table India Solid Tumors Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Solid Tumors Drugs Production by Type (2012-2017)
Table Global Solid Tumors Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Revenue by Type (2012-2017)
Table Global Solid Tumors Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Solid Tumors Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Solid Tumors Drugs by Type
Table Global Solid Tumors Drugs Price by Type (2012-2017)
Figure Global Solid Tumors Drugs Production Growth by Type (2012-2017)
Table Global Solid Tumors Drugs Consumption by Application (2012-2017)
Table Global Solid Tumors Drugs Consumption Market Share by Application (2012-2017)
Figure Global Solid Tumors Drugs Consumption Market Share by Application in 2015
Table Global Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Solid Tumors Drugs Consumption Growth Rate by Application (2012-2017)
Table Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hoffmann-La Roche Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Hoffmann-La Roche Solid Tumors Drugs Market Share (2015 and 2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novartis Solid Tumors Drugs Market Share (2015 and 2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Celgene Solid Tumors Drugs Market Share (2015 and 2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Johnson & Johnson Solid Tumors Drugs Market Share (2015 and 2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Pfizer Solid Tumors Drugs Market Share (2015 and 2016)
Table BMS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BMS Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure BMS Solid Tumors Drugs Market Share (2015 and 2016)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure AbbVie Solid Tumors Drugs Market Share (2015 and 2016)
Table AbGenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbGenomics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure AbGenomics Solid Tumors Drugs Market Share (2015 and 2016)
Table ADC Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADC Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure ADC Therapeutics Solid Tumors Drugs Market Share (2015 and 2016)
Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TG Therapeutics Solid Tumors Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure TG Therapeutics Solid Tumors Drugs Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure Global Solid Tumors Drugs Production and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumors Drugs Price and Trend Forecast (2017-2022)
Table Global Solid Tumors Drugs Production Forecast by Regions (2017-2022)
Table Global Solid Tumors Drugs Consumption Forecast by Regions (2017-2022)
Figure North America Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Solid Tumors Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Solid Tumors Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Solid Tumors Drugs Production Forecast by Type (2017-2022)
Table Global Solid Tumors Drugs Revenue Forecast by Type (2017-2022)
Table Global Solid Tumors Drugs Price Forecast by Type (2017-2022)
Table Global Solid Tumors Drugs Consumption Forecast by Application (2017-2022)

Latest News

21-Sep-2017 | Technology

Can Myntra’s Private Labels Help Global Online Shopping Market Boom?

The global online shopping market is currently on the top scale owing to the craze among the people to get the best of the products at a discounted price and at their very door step. Being one of the online shopping e-commerce giants, Myntra has come up with an idea of launching the beauty and personal care segments for its customers. The company basically aims to reach $100–150 Million b ...

21-Sep-2017 | Packaging

Changing Eating Habits To Bolstered The Growth Of Packaged Food Market In India

We are living in the phase where time is precious than any other mandatory parameters of life. There has been a drastic change in the lifestyle of people, which also includes the eating habits.

Focusing on one of the most lucrative and unpredictable markets, India, it is expected that the packaged food market in the country will jump up to a great height owing to rising popularity of ...

12-Sep-2017 | Technology

Affect Of Google’s Mistake on The Global Networking Market

The global networking market is totally dependent on the Internet. Hence, even the slightest of the error in the Internet connection can result in a huge loss for the various organizations. Google is a tech giant very well-known for its technological advancements. People spend so much of their time online without even thinking about the complex processes that take place even when just visiting ...

12-Sep-2017 | Technology

Artificial Intelligence: A Boon or a Bane for the Global Worldwide Market

We are always worrying about the climatic changes, enemy attacks, nuclear warfare, and other threats. These apocalyptic situations are enough to raise our heart beats. However, in addition to all this, there is another threat that is currently worrying a lot of researchers and public across the globe—artificial intelligence. The global worldwide market is always on the lookout for a new i ...

04-Sep-2017 | Technology

5G Technology to Boost the Internet Market In India

Internet users in the nation will increase two-fold by end of 2021 and reach from 373 Million users in 2016 to 829 Million consumers, bolstering due to the fact that almost 75% of users will be ready to pay more for 5G tech in the future. This indicates approximately 59% of the Indian populace will utilize the internet. Also, there might be 2 Billion networked gadgets by the end of 2021 up from ...